IDO1 and hepatocellular carcinoma: A high expression of IDO has been associated with increased frequencies of metastasis in patients with colorectal carcinoma [13], hepatocellular carcinoma [14], and endometrial tumors [15], and with invasive uterine cervical cancer [16].